title: Urinary test use for cancer screening: an underestimated health economics pitfall?
authors.forename: Charalampos
authors.initials: C
authors.lastname: Panou
authors.forename: Paraskevi
authors.initials: P
authors.lastname: Alevizaki
authors.forename: Davide
authors.initials: D
authors.lastname: Mauri
authors.forename: Aliki
authors.initials: A
authors.lastname: Ioakimidou
authors.forename: Angeliki
authors.initials: A
authors.lastname: Vittoraki
authors.forename: Anastasia
authors.initials: A
authors.lastname: Spiliopoulou
authors.forename: Dimitra
authors.initials: D
authors.lastname: Chasioti
authors.forename: Evridiki
authors.initials: E
authors.lastname: Loukidou
authors.forename: Georgios
authors.initials: G
authors.lastname: Kouris
authors.forename: Georgios
authors.initials: G
authors.lastname: Pentheroudakis
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D006115:Greece; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000706:statistics & numerical data; D010821:Physicians, Family; D011795:Surveys and Questionnaires; D016482:Urinalysis / Q000191:economics* / Q000706:statistics & numerical data*; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000191:economics